Skip to main content

Table 2 Summary of demographic and angiographic characteristics

From: Individual component analysis of the multi-parametric cardiovascular magnetic resonance protocol in the CE-MARC trial

 

n = 676

Age (years)

 

60.3 ± 9.5

Male gender

 

421 (62 %)

Body Mass Index (kg/m2)

 

29.0 ± 4.3

Ethnicity

White

643 (95 %)

Black

5 (1 %)

Asian

24 (4 %)

Other

4 (1 %)

Smoking status

Never smoked

236 (35 %)

Ex-smoker

315 (47 %)

Current smoker

125 (18 %)

Systolic Blood Pressure (mmHg)

 

138.1 ± 20.9

Diastolic Blood Pressure (mmHg)

 

79.0 ± 11.3

Previous admission for AMI or ACS

 

54 (8.0 %)

Previous PCI

 

37 (5 %)

Hypertension

 

347 (51 %)

Diabetes mellitus

 

85 (13 %)

 

Type I

4 (5 %)

Type II

81 (95 %)

Family history of premature CAD

Yes

392 (58 %)

No

237 (35 %)

Unknown

47 (7 %)

Total cholesterol (mmol/L)

 

5.2 (1.2)

Medication

  

Aspirin and/or Clopidogrel

 

404 (60 %)

Statin

 

301 (45 %)

ACEi/A2 Receptor Blockers

 

229 (37.2 %)

Beta-blocker

 

203 (33.0 %)

Patients undergoing X-ray angiography

Any significant stenosis

 

266 (39 %)

Triple Vessel Disease

 

40 (6 %)

Double Vessel Disease

 

83 (12 %)

Single Vessel Disease

 

143 (21 %)

LMS Disease

 

22 (3 %)

LAD Disease

 

169 (25 %)

LCx Disease

 

126 (19 %)

RCA Disease

 

105 (16 %)

  1. Mean ± standard deviation. Number (percentage)
  2. AMI acute myocardial infarction, ACS acute coronary syndrome, PCI percutaneous coronary intervention, CAD coronary artery disease, ACEi angiotensin converting enzyme inhibitor, A2 angiotensin 2, LMS left main stem, LAD left anterior descending, LCx left circumflex, RCA right coronary artery